Navigation Links
IDM Pharma Announces Phase 3 Mifamurtide (L-MTP-PE) Study Demonstrating Improved Survival Published in the Journal of Clinical Oncology
Date:2/4/2008

eceive ifosfamide and/or MTP in a 2x2 factorial design.

In the published analysis, the chemotherapy regimens without L-MTP-PE resulted in similar OS and EFS. Overall Survival after six years of follow-up in patients treated with chemotherapy and L-MTP-PE was 78%, compared to 70% in patients treated only with chemotherapy (p=0.03). The addition of L-MTP-PE to chemotherapy resulted in approximately 30% decrease in the risk of death. EFS, an additional analysis which includes the occurrence of secondary malignancies, after six years of follow-up in patients treated with chemotherapy and L-MTP-PE was 67% compared to 61% in patients treated only with chemotherapy (p=0.08).

Treatment with L-MTP-PE was generally well tolerated in all phases of study. Adverse events were mild to moderate in severity and included chills, fever, nausea, vomiting, myalgia, headache, tachycardia (fast heart rate), hypo- and hypertension, fatigue and shortness of breath, all of which are consistent events with the activation of monocytes and macrophages by L-MTP-PE and the flu-like symptoms that follow cytokine release. These side effects are readily prevented or treated with acetaminophen.

L-MTP-PE Regulatory Status

The Company recently announced that following presentation of data at an oral explanation hearing before the CHMP, the Committee determined in a non-binding opinion that L-MTPE-PE suggested a possible clinical benefit in terms of survival and granted the Company a clock stop, or time extension. The clock stop will allow the Company additional time to respond to all the remaining questions regarding the MAA.

The CHMP has requested clarification of the existing data in order to gain assurance about the quality of the data before drawing any final conclusions from the data presented. In addition, the Company is required to address a number of remaining questions relating to chemistry, manufacturing and controls (CMC). The Company now expects to receiv
'/>"/>

SOURCE IDM Pharma, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7

Related medicine technology :

1. Thomson Scientific Publishes The Ones to Watch - A Quarterly Review of Phase Changes in the Pharmaceutical Pipeline
2. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
3. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
4. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
5. Clinical Trial Effectiveness: How Pharmas & Biotechs Save Cost with Savvy Investigator Management
6. DOV Pharmaceutical, Inc. Announces Successful Phase Ib Results for DOV 21,947
7. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
8. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
9. Par Pharmaceutical Begins Shipment of Additional Dosage Strength of Generic TOPROL-XL(R)
10. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
11. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... , July 31, 2014 Marken announced today ... facilities to meet the clinical trial logistics growth in ... newly expanded facility will continue to serve as a ... to and from the region, and will provide additional ... Marken will combine its office and warehouse into a ...
(Date:7/31/2014)... 2014 De Pfizer Clinical Research Unit (PCRU) ... vrijwilligers van Japanse komaf voor medewerking aan klinisch onderzoek. ... is één van twee onderzoekseenheden van Pfizer , ... verbeteren door de ontdekking en ontwikkeling van nieuwe medicijnen. ... naar mannen en vrouwen van Japanse komaf – leeftijd ...
(Date:7/30/2014)... , July 30, 2014  Cepheid (Nasdaq: ... purchasing contract with Premier will end on September ... GPO will be able to continue their relationship ... HPA, MedAssets, Novation, and ROi, in addition to ... with Cepheid. "Cepheid has always recognized ...
Breaking Medicine Technology:Marken Expands Miami Regional Logistics Center 2Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 2Cepheid Updates Status Of Premier Group Purchasing Organization (GPO) Agreement 3
(Date:7/31/2014)... Healthinsurancefacts.org has released a new blog post explaining how ... , In order to find affordable individual health ... can do this by visiting an insurance brokerage website ... should do proper research when looking for health insurance. ... of them can be advantageous in the appropriate context. ...
(Date:7/31/2014)... The National Cannabis Industry Association ... York on Thursday, August 7, from noon to 4pm ... keynotes by State Senator Diane J. Savino (D-Staten Island) ... include lunch and in-depth discussions on the recent passage ... is doing federally to advance a legitimate and responsible ...
(Date:7/31/2014)... (PRWEB) July 31, 2014 According to a ... Bush recently underwent partial knee replacement surgery on his left ... than two months earlier. The story also reports that Bush ... and hopes to be back on the bike again soon. ... the benefits of partial knee replacement. , “Partial knee ...
(Date:7/31/2014)... ProtonPACS, a division of Radsource, has signed ... Health Association (NRHA), company officials announced today. The partnership ... of rural health providers nationwide. , “We are proud ... Dr. Mark Awh, President of Radsource. “While we are ... are also looking forward to learning from all of ...
(Date:7/31/2014)... (August 1, 2014) While it is known that members ... use alcohol, a new study finds that female enlistees ... than their civilian counterparts. This study was published today ... journal published on behalf of the Inter-University Seminar on ... and Lucky Tedrow studied surveys of nearly 9,000 men ...
Breaking Medicine News(10 mins):Health News:Comparing Health Insurance Quotes Can Help Clients Find Affordable Plans 2Health News:THURSDAY, AUG 7: First-Ever National Cannabis Industry Association Event in New York Will Feature Senator Savino, Assemblyman Katz, & Industry Leaders 2Health News:George W. Bush’s Surgery Highlights the Benefits of Partial Knee Replacement 2Health News:ProtonPACS Announces Pipeline Partnership with the National Rural Health Association. 2Health News:Women in military less likely to drink than civilian women 2
... of Infection Control and Hospital Epidemiology finds that ... Staphylococcus aureus (MRSA), and suggests that some nursing homes ... bacteria, which can lead to hard-to-treat infections. The study, ... found that 31 percent of the residents who were tested ...
... Mozes HealthDay Reporter , WEDNESDAY, Dec. 1 (HealthDay ... of radiation exposure from CT scans may be lower than ... to be presented Wednesday at the annual meeting of the ... an eight-year analysis of Medicare records covering nearly 11 million ...
... , WEDNESDAY, Dec. 1 (HealthDay News) -- Deployment to ... of sleep of many U.S. military personnel, new research ... members of the U.S. military before they deployed to ... Dec. 1 issue of the journal Sleep . ...
... , Glucocorticoid drugs are used widely to ... and some forms of cancer, and transplant recipients. The ... and immunosuppressive properties. However, their long-term use is limited ... glucose, fatty liver, and type 2 diabetes. A team ...
... Researchers from Boston University School of Medicine (BUSM) have ... agents can enter and kill cancer cells. This finding, which ... Journal of Virology , could help lead to the development ... The study was conducted by Ewan F. Dunn, a postdoctoral ...
... in French . Montreal, December 1st, 2010 ... more closely connected than previously imagined. The damaging effects of ... also affect the brain. In fact, infarction seems to cause ... to insomnia, notably paradoxical insomnia. Sleep plays a crucial role ...
Cached Medicine News:Health News:MRSA carriage rates vary widely in nursing homes, study finds 2Health News:CT Scans May Pose Less Cancer Risk Than Thought, Study Contends 2Health News:CT Scans May Pose Less Cancer Risk Than Thought, Study Contends 3Health News:Military Deployment May Lead to Unhealthy Sleep Patterns 2Health News:JCI online early table of contents: Dec. 1, 2010 2Health News:JCI online early table of contents: Dec. 1, 2010 3Health News:JCI online early table of contents: Dec. 1, 2010 4Health News:JCI online early table of contents: Dec. 1, 2010 5Health News:JCI online early table of contents: Dec. 1, 2010 6Health News:JCI online early table of contents: Dec. 1, 2010 7Health News:JCI online early table of contents: Dec. 1, 2010 8Health News:JCI online early table of contents: Dec. 1, 2010 9Health News:JCI online early table of contents: Dec. 1, 2010 10Health News:Insomnia after myocardial infarction 2
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... is a national reference laboratory and a ... development. ARUP offers an extensive test menu ... in clinical and anatomic pathology. Owned by ... include more than half of the nation's ...
Medicine Products: